# Altered Endothelin Receptor Expression in Idiopathic Male Infertility: A Potential Therapeutic Target

**Authors:** Richard Weiten, Melanie V. Brandenstein, Manuel Huerta, Tim Nestler, Axel Heidenreich, Enno Storz, Jan Herden

PMC · DOI: 10.5152/tud.2025.24104 · Urology Research and Practice · 2025-05-21

## TL;DR

This study explores how changes in endothelin receptor expression may contribute to male infertility, suggesting new treatment possibilities.

## Contribution

The study identifies altered endothelin receptor expression in idiopathic male infertility and suggests potential therapeutic targets.

## Key findings

- ETAR expression was significantly reduced in infertile men compared to fertile controls.
- ETBR was undetectable in all OAT syndrome samples.
- Two distinct ETAR expression profiles were observed in the OAT group, indicating phenotypic heterogeneity.

## Abstract

Idiopathic male infertility is frequently associated with impaired semen quality, particularly in men diagnosed with oligo-astheno-teratozoospermia (OAT) syndrome. Recent studies suggest a potential role of the endothelin (ET) system, particularly ET receptors A (ETAR) and B (ETBR), in male reproductive physiology. Moreover, antiestrogens such as tamoxifen and clomiphene, which are commonly used empirically in this context, may influence ET signaling pathways. However, the relationship between ET receptor expression and specific subtypes of male infertility remains poorly understood.

Semen samples were collected from 56 men: 15 fertile controls with normozoospermia and 41 infertile men with abnormal semen parameters, including 22 with OAT syndrome and 19 with isolated teratozoospermia. Men with identifiable female-factor infertility were excluded. Seminal ETAR and ETBR expression were analyzed using immunofluorescence microscopy, Western blotting, enzyme-linked immunosorbent assay (ELISA), and flow cytometry.

The ETAR expression was significantly reduced in infertile men compared to fertile controls (P < .05). The ETBR was undetectable in all samples from patients with OAT syndrome. Notably, 2 distinct ETAR expression profiles were observed within the OAT group: one subgroup with ETAR levels comparable to controls and another with markedly diminished expression, indicating potential phenotypic heterogeneity within OAT syndrome.

Altered ETAR expression and the absence of ETBR in men with idiopathic infertility, particularly those with OAT syndrome, highlight a potential role for ET signaling in male reproductive dysfunction. Stratification based on ETAR expression may support individualized therapeutic strategies, including ET-targeted or antiestrogen-based therapies, to improve fertility outcomes in this population.

## Linked entities

- **Proteins:** EDNRA (endothelin receptor type A), EDNRB (endothelin receptor type B)
- **Chemicals:** tamoxifen (PubChem CID 2733526), clomiphene (PubChem CID 2800)

## Full-text entities

- **Genes:** MFSD11 (major facilitator superfamily domain containing 11) [NCBI Gene 79157] {aka ET}, EDNRB (endothelin receptor type B) [NCBI Gene 1910] {aka ABCDS, ET-B, ET-BR, ETB, ETB1, ETBR}, EDNRA (endothelin receptor type A) [NCBI Gene 1909] {aka ET-A, ETA, ETA-R, ETAR, ETRA, MFDA}
- **Diseases:** idiopathic infertility (MESH:D007246), male reproductive dysfunction (MESH:D005832), Idiopathic Male Infertility (MESH:D007248), teratozoospermia (MESH:D000072660), female- factor infertility (MESH:D007247), OAT (MESH:D053627)
- **Chemicals:** tamoxifen (MESH:D013629), clomiphene (MESH:D002996)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12128351/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12128351/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12128351/full.md

---
Source: https://tomesphere.com/paper/PMC12128351